All Pharma News
Syncona announces sale of portfolio company to Novartis

Syncona announces sale of portfolio company to Novartis
John Pinching PHARMATIMES
18 Feb 2022
Share Share
Novartis Bolsters Retinal Gene Therapy Position with $1.5 Billion Acquisition

Novartis Bolsters Retinal Gene Therapy Position with $1.5 Billion Acquisition
Alex Keown BIOSPACE
23 Dec 2021
Share Share
Novartis buys UK`s Gyroscope for $1.5B to get gene therapy for eye disease

Novartis buys UK`s Gyroscope for $1.5B to get gene therapy for eye disease
REUTERS
21 Dec 2021
Share Share
Sanofi invests $40m in UK gene therapy company Gyroscope Therapeutics

Sanofi invests $40m in UK gene therapy company Gyroscope Therapeutics
Lucy Parsons PHARMATIMES
09 Nov 2021
Share Share
Gyroscope spins the wheel again as it taps Sanofi for $60M

Gyroscope spins the wheel again as it taps Sanofi for $60M
Phil Taylor PHARMAPHORUM
09 Nov 2021
Share Share
Eye-focused gene therapy startup gets $60M cash infusion from Sanofi

Eye-focused gene therapy startup gets $60M cash infusion from Sanofi
Jonathan Gardner BIOPHARMADIVE
08 Nov 2021
Share Share
AI upstart grabs $40M launch round; Sanofi backs gene therapy player; & more

AI upstart grabs $40M launch round; Sanofi backs gene therapy player; & more
Paul Schloesser\nJohn Carroll ENDPTS
08 Nov 2021
Share Share
Gyroscope Announces Presentation of Positive Interim Phase I/II Data GT005

Gyroscope Announces Presentation of Positive Interim Phase I/II Data GT005
GYROSCOPETX
30 Sep 2021
Share Share
Gyros Protein Technologies and Cygnus Technologies Expand Collaboration

Gyros Protein Technologies and Cygnus Technologies Expand Collaboration
BUSINESSWIRE
08 Jul 2021
Share Share
Gyroscope Therapeutics withdraws plans for IPO

Gyroscope Therapeutics withdraws plans for IPO
Jonathan.M SEEKING ALPHA
10 Jun 2021
Share Share